EP2043659
ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.7.2007EP published:
3.4.2013EP application number:
07766866.3
EPO information:
European Patent Register
Max expiry date:
3.7.2027
Title:
ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
Timeline
Today
4.7.2007EP application
3.4.2013EP Publication
Owner
Name:
Tiltan Pharma LtdAddress:
1-1 Hi-Tech Village Edmond Safra Campus Givat Ram P.O.B. 39026, 91390, Jerusalem, IL
Inventor
Name:
BEN-SASSON, Shmuel A.Address:
Jerusalem, IL
Priority
Number:
819164 PDate:
7.7.2006Country:
US
Number:
880107 PDate:
12.1.2007Country:
US
Classification
Categories:
A61K 31/675, A61K 45/06, A61K 31/196, A61K 31/415, A61K 31/425, A61K 31/4402, A61P 35/00, A61K 31/203